Why I'm Wary Of GRAIL And Its Plan To Develop A Cancer Blood Test

Published: Jan 09, 2017

Last week, a big biotech company announced that it’s spinning off a smaller company. Illumina is a DNA sequencing giant, and Grail is its ambitious child. Grail aims to spot cancer early by detecting genetic changes in blood of apparently healthy people.

I admire the goal of early cancer detection, but think this a fool’s mission.

Back to news